![India's first nasal Covid vaccine iNCOVACC launched; priced at ₹325/dose](https://images.assettype.com/fortuneindia%2F2023-01%2Fc10ecc65-7294-45d6-b2b9-79b3aeacdb90%2FInco.jpg?w=300&q=95)
India's first nasal Covid vaccine iNCOVACC launched; priced at ₹325/dose
Bharat Biotech’s vaccine dubbed as “game changer”; to offer efficient distribution and easy and pain-free administration.
Bharat Biotech’s vaccine dubbed as “game changer”; to offer efficient distribution and easy and pain-free administration.
The iNCOVACC vaccine received Indian drug regulator's approval to be used as a booster dose for the adult population.
iNCOVACC becomes the world’s first intranasal vaccine to receive both primary series and heterologous booster approval.